Lv41
506 积分 2022-09-27 加入
Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer
2个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
2个月前
已完结
Sex Differences in Cancer Stage at Diagnosis of Nonreproductive Solid Organ Tumors in the United States, 2015 to 2022
3个月前
已完结
Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial
3个月前
已完结
Causes and consequences of discontinuation of GLP1RAs or tirzepatide
3个月前
已完结
Comparative analysis of monthly weight-regain dynamics after discontinuation of semaglutide vs tirzepatide
3个月前
已关闭
Multireceptor modulation in metabolic disease: are more targets better?
4个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumabfor HER2-Positive Metastatic Breast Cancer
5个月前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
5个月前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
5个月前
已完结
皖公网安备34019202002308
